https://stemina.com/wp-content/uploads/NPDX_DAmaral-e1539809653654.jpg
300
300
admini
https://stemina.com/wp-content/uploads/Stemina-Biomarker-Discovery-Logo-475x140.png
admini2018-02-12 18:30:332019-09-24 16:24:05David G. Amaral, Ph.D.Both Stemina Biomarker Discovery and NeuroPointDX benefit from the intelligence, leadership, and experience of these professionals.
https://stemina.com/wp-content/uploads/NPDX_DAmaral-e1539809653654.jpg
300
300
admini
https://stemina.com/wp-content/uploads/Stemina-Biomarker-Discovery-Logo-475x140.png
admini2018-02-12 18:30:332019-09-24 16:24:05David G. Amaral, Ph.D.
Robert E. Burrier, Ph.D.
Chief Operation Officer, Vice President of Research & Development, Stemina Biomarker Discovery

Oliver Fiehn, Ph.D.
University of California, Davis; NIH West Coast Metabolomics Center

Steven Fischer
Marketing Director, Academia and Government, Agilent Technologies

Minesh Mehta, MB, ChB
Professor and Chair, Radiation Oncology, Florida Internationals University; Deputy Director, Miami Cancer Institute; Chief of Radiation Oncology, Baptist Health

Marvin Natowicz, MD, PhD
Professor of Pathology, Cleveland Clinic Lerner College of Medicine of Case Western Reserve University; Physician at Cleveland Clinic

Denise M. Ney, PhD, Registered Dietitian Nutritionist (RDN)
Professor of Nutritional Sciences, University of Wisconsin - Madison

G. Sitta Sittampalam, PhD
Senior Advisor to the Director, National Center for Advancing Translational Sciences, National Institutes of Health
Interesting links
Here are some interesting links for you! Enjoy your stay :)Pages
- A Targeted Metabolomics-Based Assay Using Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes Identifies Structural and Functional Cardiotoxicity Potential
- About Stemina
- Application of the Biomarker-Based In Vitro Assays devTOX quickPredict and Cardio quickPredict for Toxicity Screening
- Archive
- Board of Directors
- Cardio quickPredict
- Careers
- Contact
- Custom Services
- Defining the Reproducibility and Applicability Domain of devTOX quickPredict, a Human Pluripotent Stem Cell-Based Developmental Toxicity Assay
- Developmental Computation with Embryonic Stem Cells
- devTOX quickPredict FAQs
- Home
- In Vitro to In Vivo Extrapolation for Developmental Toxicity Potency of Valproate Analogues
- Journal Publications
- Leadership
- Neurodevelopmental Division
- News
- Posters
- Predicting Developmental Toxicity Potential Using Pluripotent Embryonic Stem Cell Assays and the ToxCast Library
- Presentations
- Press Releases
- Privacy Policy
- Resources
- Scientific Advisory Board
- Upcoming Events
- Webinars
- devTox quickPredict
Categories
Archive
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- August 2021
- March 2021
- February 2021
- November 2020
- October 2020
- April 2020
- March 2020
- February 2020
- November 2019
- June 2019
- March 2019
- November 2018
- October 2018
- September 2018
- July 2018
- June 2018
- March 2018
- February 2018
- January 2018
- November 2017
- October 2017
- September 2017
- August 2017
- June 2017
- March 2017
- February 2017
- January 2017
- November 2016
- October 2016
- July 2016
- May 2016
- March 2016
- November 2015
- June 2015
- March 2015
- August 2014
- March 2014
- January 2014
- November 2013
- September 2013
- August 2013
- June 2013
- March 2013
- February 2013
- November 2012
- August 2012
- January 2012
- November 2011
- August 2010
- June 2010
- May 2010
- September 2009
- June 2009
- December 2007
